\
&
Contact us
\
&
Contact us
Tips and tricks are elaborated in Horizon 2020 for beginners-general introduction powerpoint. Many of the priniples still apply under Horizon Europe, but since there are some novelties introduced under Horizon Europe, an updated presentation will be made available in the future.
In the Horizon 2020 for beginners-evaluation criteria (second half of the file) presentation, the steps of the evaluation process are elaborated in detail, which provides you with tips and tricks to write a good proposal.
There exist several tools and organisations that can help you to find the right partners for your Horizon 2020 project. You can find an overview on our partner search page.
Need a helping hand? The NCP advisor in your field is open to receive your questions about the call topics of the programme of your interest.
We are organised by programme domain. Get the right contact details of whom to turn to for which programme section.
Administrative, legal and financial issues are elaborated in Support for Legal and Financial issues.
The NCP advisor is open to receive your all your questions related to the Horizon 2020 calls. In the contact us section you can find the contact details of whom to turn to for which programme section.
Administrative, legal and financial issues are elaborated in Support for Legal and Financial issues.
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
